Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program. (February 2019)

• Record Type: Journal Article
• Authors: Jiang, Huan; Walter, Stephen D.; Brown, Patrick; Raina, Parminder; Chiarelli, Anna M.
• Is Part Of: Breast. Volume 43(2019)
• Page Start: 105
• Page End: 112
• Publication Date: 2019-02
• Subjects: Mammography -- Breast clinical examination -- Clustered analysis -- Detection rate -- Sensitivity -- Specificity; ACS American Cancer Society -- IARC International Agency for Research on Cancer -- CBE clinical breast exam -- OBSP Ontario Breast Screening Program -- OCR Ontario Cancer Registry; Breast -- Diseases -- Periodicals; Breast -- Tumors -- Periodicals; Breast -- Periodicals; Electronic journals; Periodicals; 616
• DOI: 10.1016/j.breast.2018.11.012
• Languages: English
• ISSNs: 0960-9776

Abstract

Abstract: Background: There is controversy about the value of clinical breast examination (CBE) in addition to mammography for breast screening. The study investigates the associations between risk factors such as mammographic density, hormone therapy use and family history and the effectiveness of screening mammography with or without CBE. Methods: The cohort consists of women 50–69 years old screened at the Ontario Breast Screening Program. The associations of the risk factors were investigated using a joint logistic regression model that accommodates the partially unobserved disease status, clustered data structures, individual risk factors, and the dependence between true and false detection. Results: Having high mammographic density, a first degree relative with breast cancer and using hormone therapy generally increased a woman's probability of being referred correctly. For low risk group (defined as without dense breasts, family history, and not currently using hormone therapy), the average loss of specificity ranged from 3.6% to 5.7% and the gain of sensitivity was between 10.6% and 21.2% with the addition of CBE. Conclusions: The addition of CBE to mammography would increase the overall sensitivity and decrease the specificity. CBE can be targeted to those women in which it has the highest net benefit. Highlights: This study provides evidence to evaluate the benefits and harms of clinical breast exam in conjunction with mammography using observational cohort data. Having high mammographic density, a first degree relative with breast cancer and using hormone therapy generally increased a woman's chance of being referred correctly. The addition of clinical breast exam to mammography would increase the overall sensitivity and decrease the specificity. The study found that clinical breast exam may benefit older low-risk women and women receiving hormone therapy when offered in addition to mammography.